Chi‐An Cheng

1.9k total citations
32 papers, 1.2k citations indexed

About

Chi‐An Cheng is a scholar working on Infectious Diseases, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Chi‐An Cheng has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Materials Chemistry. Recurrent topics in Chi‐An Cheng's work include SARS-CoV-2 and COVID-19 Research (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Extracellular vesicles in disease (4 papers). Chi‐An Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and Extracellular vesicles in disease (4 papers). Chi‐An Cheng collaborates with scholars based in United States, Taiwan and China. Chi‐An Cheng's co-authors include Jeffrey I. Zink, Wei Chen, Huan‐Cheng Chang, Chin-Hsiang Chien, Wei-Wei Chang, Yung Kuo, Tsai‐Jung Wu, Yan‐Kai Tzeng, John Yu and Jakob G. P. Lingg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Chi‐An Cheng

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐An Cheng United States 15 520 516 296 282 161 32 1.2k
María J. Marín United Kingdom 20 514 1.0× 505 1.0× 203 0.7× 408 1.4× 42 0.3× 47 1.4k
Katy N. Olafson United States 12 400 0.8× 359 0.7× 419 1.4× 313 1.1× 42 0.3× 15 1.4k
Zheyu Wang United States 19 707 1.4× 289 0.6× 177 0.6× 613 2.2× 101 0.6× 42 1.5k
Fuminori Sugihara Japan 24 844 1.6× 919 1.8× 252 0.9× 497 1.8× 110 0.7× 59 2.4k
Eun-Jin Cho South Korea 10 905 1.7× 745 1.4× 910 3.1× 457 1.6× 126 0.8× 13 1.9k
Pradip Dey India 18 325 0.6× 228 0.4× 313 1.1× 305 1.1× 45 0.3× 45 1.1k
Jeyarama S. Ananta United States 21 1.1k 2.1× 625 1.2× 519 1.8× 455 1.6× 61 0.4× 23 1.9k
Anthony J. Kim United States 25 704 1.4× 393 0.8× 500 1.7× 958 3.4× 36 0.2× 37 2.2k
Hang Liu China 24 1.0k 1.9× 347 0.7× 405 1.4× 446 1.6× 33 0.2× 43 1.7k
Joan Comenge Spain 12 825 1.6× 823 1.6× 303 1.0× 597 2.1× 36 0.2× 18 2.0k

Countries citing papers authored by Chi‐An Cheng

Since Specialization
Citations

This map shows the geographic impact of Chi‐An Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐An Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐An Cheng more than expected).

Fields of papers citing papers by Chi‐An Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐An Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐An Cheng. The network helps show where Chi‐An Cheng may publish in the future.

Co-authorship network of co-authors of Chi‐An Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐An Cheng. A scholar is included among the top collaborators of Chi‐An Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐An Cheng. Chi‐An Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hsiao, Wesley Wei‐Wen, et al.. (2024). Exploring nanodiamonds: leveraging their dual capacities for anticancer photothermal therapy and temperature sensing. Nanoscale. 16(32). 14994–15008. 4 indexed citations
3.
Cheng, Chi‐An, et al.. (2023). Ultrasensitive and High‐Resolution Protein Spatially Decoding Framework for Tumor Extracellular Vesicles. Advanced Science. 11(3). e2304926–e2304926. 9 indexed citations
4.
Sherman, Amy C, Chi‐An Cheng, Zoe Swank, et al.. (2023). Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(5). 337.e1–337.e5. 5 indexed citations
5.
Cheng, Chi‐An, et al.. (2023). Integrated pipeline for ultrasensitive protein detection in cancer nanomedicine. RSC Advances. 13(21). 14685–14697. 5 indexed citations
6.
Nie, Kun, Xuyi Wang, Chi‐An Cheng, et al.. (2023). Cesium manganese halide perovskite-analogue nanocrystals with highly efficient energy conversion for flexible multifunctional fibers. Inorganic Chemistry Frontiers. 10(4). 1338–1347. 5 indexed citations
7.
Nie, Kun, Ranran Zhou, Chi‐An Cheng, et al.. (2022). Structure, luminescence properties and energy transfer of terbium and samarium co-doped barium based apatite phosphor with tunable emission colour. Heliyon. 8(12). e12566–e12566. 4 indexed citations
8.
Gilboa, Tal, Limor Cohen, Chi‐An Cheng, et al.. (2021). A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays. Angewandte Chemie International Edition. 60(49). 25966–25972. 23 indexed citations
9.
Gilboa, Tal, Limor Cohen, Chi‐An Cheng, et al.. (2021). A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays. Angewandte Chemie. 133(49). 26170–26176. 4 indexed citations
10.
Ogata, Alana F., et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses. Clinics in Laboratory Medicine. 42(1). 97–109. 1 indexed citations
11.
Chen, Wei, et al.. (2021). Expanding nanoparticle multifunctionality: size-selected cargo release and multiple logic operations. Nanoscale. 13(10). 5497–5506. 6 indexed citations
12.
Ogata, Alana F., Chi‐An Cheng, Michaël Desjardins, et al.. (2021). Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clinical Infectious Diseases. 74(4). 715–718. 139 indexed citations
13.
14.
Cheng, Chi‐An, et al.. (2019). Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome. Nanotheranostics. 3(2). 166–178. 31 indexed citations
15.
Cheng, Chi‐An, Wei Chen, Le Zhang, Holden H. Wu, & Jeffrey I. Zink. (2019). A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose. Journal of the American Chemical Society. 141(44). 17670–17684. 82 indexed citations
16.
Chen, Wei, et al.. (2018). Stimuli-Responsive Nanomachines and Caps for Drug Delivery. ˜The œEnzymes. 43. 31–65. 15 indexed citations
17.
Chen, Wei, Chi‐An Cheng, Bai‐Yu Lee, et al.. (2018). Facile Strategy Enabling Both High Loading and High Release Amounts of the Water-Insoluble Drug Clofazimine Using Mesoporous Silica Nanoparticles. ACS Applied Materials & Interfaces. 10(38). 31870–31881. 56 indexed citations
18.
Wu, Tsai‐Jung, Yan‐Kai Tzeng, Wei-Wei Chang, et al.. (2013). Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds. Nature Nanotechnology. 8(9). 682–689. 196 indexed citations
19.
Fang, Chia‐Yi, et al.. (2011). The Exocytosis of Fluorescent Nanodiamond and Its Use as a Long‐Term Cell Tracker. Small. 7(23). 3363–3370. 106 indexed citations
20.
Hochwald, G. M., Chengcheng Huang, Tao Hong, et al.. (1998). Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-β1. Proceedings of the National Academy of Sciences. 95(21). 12516–12521. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026